The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
The Human Cytomegalovirus UL11 Protein Interacts with the Receptor Tyrosine Phosphatase CD45, Resulting in Functional Paralysis of T Cells
Open accessAbstract
Human cytomegalovirus (CMV) exerts diverse and complex effects on the immune system, not all of which have been attributed to viral genes. Acute CMV infection results in transient restrictions in T cell proliferative ability, which can impair the control of the virus and increase the risk of secondary infections in patients with weakened or immature immune systems. In a search for new immunomodulatory proteins, we investigated the UL11 protein, a member of the CMV RL11 family. This protein family is defined by the RL11 domain, which has homology to immunoglobulin domains and adenoviral immunomodulatory proteins. We show that pUL11 is expressed on the cell surface and induces intercellular interactions with leukocytes. This was demonstrated to be due to the interaction of pUL11 with the receptor tyrosine phosphatase CD45, identified by mass spectrometry analysis of pUL11-associated proteins. CD45 expression is sufficient to mediate the interaction with pUL11 and is required for pUL11 binding to T cells, indicating that pUL11 is a specific CD45 ligand. CD45 has a pivotal function regulating T cell signaling thresholds; in its absence, the Src family kinase Lck is inactive and signaling through the T cell receptor (TCR) is therefore shut off. In the presence of pUL11, several CD45-mediated functions were inhibited. The induction of tyrosine phosphorylation of multiple signaling proteins upon TCR stimulation was reduced and T cell proliferation was impaired. We therefore conclude that pUL11 has immunosuppressive properties, and that disruption of T cell function via inhibition of CD45 is a previously unknown immunomodulatory strategy of CMV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






![Figure 7 pUL11 treatment results in reduced T cell signaling and proliferation. (A) Immunoblot with the 4G10 phosphotyrosine-specific antibody (upper panel) or anti-actin (lower panel) of lysates from Jurkat cells that were either left untreated or were pretreated with UL11Fc or the Fc domain (2.5 µg) for 30 min prior to stimulation with a Jurkat TCR-specific antibody (C305) for the indicated times. (B) Primary T cells were either left untreated (medium) or were incubated with the CD3-specific antibody OKT3 or with phytohaemagglutinin (PHA) together with BSA, UL11Fc or the Fc domain (2 µg) for 3 days. Following incubation for 16 h with 3[H]-thymidine radionucleotide incorporation was measured. All samples were handled in triplicate. Representative data from one of three experiments are shown.](https://figures.cochat.ai/paper-figures/b98294d6176f47ddaa6e6710bb2340af/the-human-cytomegalovirus-ul11-protein-interacts-with-the-receptor-tyrosine-figure-7.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“pUL11 binding reduced tyrosine phosphorylation, leading to inhibition of T cell proliferation (66).”
From The Impact of Mass Spectrometry–Based Proteomics on Fundamental Discoveries in Virology (2014) · cites this paper as [66]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Varki, A. P., Cummings, R. D., Esko, J. D., Freeze, H. H., Stanley, P., Bertozzi, C. R., Hart, G. W., & Etzler, M. E. (1999) · Cited by 2,384
Smith-Garvin, J. E., Koretzky, G. A., & Jordan, M. S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132706 · Cited by 2,144
Straus, D. (1992) · Cell · doi:10.1016/0092-8674(92)90428-f · Cited by 1,034
CD45: A Critical Regulator of Signaling Thresholds in Immune Cells
Hermiston, M. L., Xu, Z., & Weiss, A. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.140946 · Cited by 946
Recognition of a virus-encoded ligand by a natural killer cell activation receptor
Smith, H. R. C., Heusel, J. W., Mehta, I. K., Kim, S., Dorner, B. G., Naidenko, O. V., Iizuka, K., Furukawa, H., Beckman, D. L., Pingel, J. T., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092258599 · Cited by 767
The Leukocyte Common Antigen Family
Thomas, M. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.002011 · Cited by 730
High-titer packaging cells producing recombinant retroviruses resistant to human serum
Cosset, F. L., Takeuchi, Y., Battini, J. L., Weiss, R. A., & Collins, M. K. (1995) · Journal of Virology · doi:10.1128/jvi.69.12.7430-7436.1995 · Cited by 661
Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains
Cha, T. A., Tom, E., Kemble, G. W., Duke, G. M., Mocarski, E. S., & Spaete, R. R. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.78-83.1996 · Cited by 611
Genetic content of wild-type human cytomegalovirus
Dolan, A., Cunningham, C., Hector, R. D., Hassan-Walker, A. F., Lee, L., Addison, C., Dargan, D. J., McGeoch, D. J., Gatherer, D., Emery, V. C., et al. (2004) · Journal of General Virology · doi:10.1099/vir.0.79888-0 · Cited by 557
Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10)
Kotenko, S. V., Saccani, S., Izotova, L. S., Mirochnitchenko, O. V., & Pestka, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1695 · Cited by 519
Weiss, A., & Stobo, J. D. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.5.1284 · Cited by 493
Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation
Yamaguchi, H., & Hendrickson, W. A. (1996) · Nature · doi:10.1038/384484a0 · Cited by 492
Kishihara, K., Penninger, J., Wallace, V. A., Kündig, T. M., Kawal, K., Wakeham, A., Timms, E., Pfeffer, K., Ohashi, P. S., Thomas, M. L., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90302-7 · Cited by 490
Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis.
Carney, W. P., Rubin, R. H., Hoffman, R. A., Hansen, W. P., Healey, K., & Hirsch, M. S. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.6.2114 · Cited by 477
Ostergaard, H. L., Shackelford, D. A., Hurley, T. R., Johnson, P., Hyman, R., Sefton, B. M., & Trowbridge, I. S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.8959 · Cited by 463
Barber, E. K., Dasgupta, J. D., Schlossman, S. F., Trevillyan, J. M., & Rudd, C. E. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.9.3277 · Cited by 452
Koretzky, G. A., Picus, J., Thomas, M. L., & Weiss, A. (1990) · Nature · doi:10.1038/346066a0 · Cited by 451
Borst, E.-M., Hahn, G., Koszinowski, U. H., & Messerle, M. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8320-8329.1999 · Cited by 384
Self-citationSinzger, C., Hahn, G., Digel, M., Katona, R., Sampaio, K. L., Messerle, M., Hengel, H., Koszinowski, U., Brune, W., & Adler, B. (2008) · Journal of General Virology · doi:10.1099/vir.0.83286-0 · Cited by 376
Self-citationByth, K. F., Conroy, L. A., Howlett, S., Smith, A. J., May, J., Alexander, D. R., & Holmes, N. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1707 · Cited by 373
Salmond, R. J., Filby, A., Qureshi, I., Caserta, S., & Zamoyska, R. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00745.x · Cited by 353
Staging and resetting T cell activation in SMACs
Freiberg, B. A., Kupfer, H., Maslanik, W., Delli, J., Kappler, J., Zaller, D. M., & Kupfer, A. (2002) · Nature Immunology · doi:10.1038/ni836 · Cited by 349
Manifestations of Human Cytomegalovirus Infection: Proposed Mechanisms of Acute and Chronic Disease
Britt, W. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-77349-8_23 · Cited by 345
van Oers, N. S., Killeen, N., & Weiss, A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.1053 · Cited by 332
Structural basis for inhibition of receptor protein-tyrosine phosphatase-α by dimerization
Bilwes, A. M., den Hertog, J., Hunter, T., & Noel, J. P. (1996) · Nature · doi:10.1038/382555a0 · Cited by 324
Potent Immunosuppressive Activities of Cytomegalovirus- Encoded Interleukin-10
Spencer, J. V., Lockridge, K. M., Barry, P. A., Lin, G., Tsang, M., Penfold, M. E. T., & Schall, T. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.3.1285-1292.2002 · Cited by 322
Kung, C., Pingel, J. T., Heikinheimo, M., Klemola, T., Varkila, K., Yoo, L. I., Vuopala, K., Poyhonen, M., Uhari, M., Rogers, M., et al. (2000) · Nature Medicine · doi:10.1038/73208 · Cited by 313
Powell, L. D., & Varki, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14243 · Cited by 312
Membrane proteins with immunoglobulin-like domains—a master superfamily of interaction molecules
Barclay, A. N. (2003) · Seminars in Immunology · doi:10.1016/s1044-5323(03)00047-2 · Cited by 309
Sia, I. G., & Patel, R. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.1.83 · Cited by 284
Ligand-mediated negative regulation of a chimeric transmembrane receptor tyrosine phosphatase
Desai, D. M., Sap, J., Schlessinger, J., & Weiss, A. (1993) · Cell · doi:10.1016/0092-8674(93)90141-c · Cited by 277
Mechanisms of Immunosuppression in Cytomegaloviral Mononucleosis
Rinaldo, C. R., Carney, W. P., Richter, B. S., Black, P. H., & Hirsch, M. S. (1980) · Journal of Infectious Diseases · doi:10.1093/infdis/141.4.488 · Cited by 275
Human cytomegalovirus immunity and immune evasion
Jackson, S. E., Mason, G. M., & Wills, M. R. (2011) · Virus Research · doi:10.1016/j.virusres.2010.10.031 · Cited by 262
Majeti, R., Xu, Z., Parslow, T. G., Olson, J. L., Daikh, D. I., Killeen, N., & Weiss, A. (2000) · Cell · doi:10.1016/s0092-8674(00)00209-9 · Cited by 250
Structure of the regulatory domains of the Src-family tyrosine kinase Lck
Eck, M. J., Atwell, S. K., Shoelson, S. E., & Harrison, S. C. (1994) · Nature · doi:10.1038/368764a0 · Cited by 242
Modulation of natural killer cells by human cytomegalovirus
Wilkinson, G. W. G., Tomasec, P., Stanton, R. J., Armstrong, M., Prod’homme, V., Aicheler, R., McSharry, B. P., Rickards, C. R., Cochrane, D., Llewellyn-Lacey, S., et al. (2008) · Journal of Clinical Virology · doi:10.1016/j.jcv.2007.10.027 · Cited by 239
Self-citationMarth, J. D., Cooper, J. A., King, C. S., Ziegler, S. F., Tinker, D. A., Overell, R. W., Krebs, E. G., & Perlmutter, R. M. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.2.540 · Cited by 230
van Vliet, S. J., Gringhuis, S. I., Geijtenbeek, T. B. H., & van Kooyk, Y. (2006) · Nature Immunology · doi:10.1038/ni1390 · Cited by 216
Amano, M., Galvan, M., He, J., & Baum, L. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209595200 · Cited by 212
Cheung, T. C., Humphreys, I. R., Potter, K. G., Norris, P. S., Shumway, H. M., Tran, B. R., Patterson, G., Jean-Jacques, R., Yoon, M., Spear, P. G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506172102 · Cited by 209
Targeting the Function of Mature Dendritic Cells by Human Cytomegalovirus
Raftery, M. J., Schwab, M., Eibert, S. M., Samstag, Y., Walczak, H., & Schönrich, G. (2001) · Immunity · doi:10.1016/s1074-7613(01)00239-4 · Cited by 208
Amrein, K. E., & Sefton, B. M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4247 · Cited by 206
Cytomegalovirus Reinfections in Healthy Seroimmune Women
Ross, S. A., Arora, N., Novak, Z., Fowler, K. B., Britt, W. J., & Boppana, S. B. (2010) · The Journal of Infectious Diseases · doi:10.1086/649903 · Cited by 204
Tu, W., Chen, S., Sharp, M., Dekker, C., Manganello, A. M., Tongson, E. C., Maecker, H. T., Holmes, T. H., Wang, Z., Kemble, G., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.3260 · Cited by 201
McNeill, L., Salmond, R. J., Cooper, J. C., Carret, C. K., Cassady-Cain, R. L., Roche-Molina, M., Tandon, P., Holmes, N., & Alexander, D. R. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.015 · Cited by 189
Cytomegalovirus Immune Evasion
Powers, C., DeFilippis, V., Malouli, D., & Früh, K. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-77349-8_19 · Cited by 185
Atalay, R., Zimmermann, A., Wagner, M., Borst, E., Benz, C., Messerle, M., & Hengel, H. (2002) · Journal of Virology · doi:10.1128/jvi.76.17.8596-8608.2002 · Cited by 183
Self-citationA Deletion in the Gene Encoding the CD45 Antigen in a Patient with SCID
Tchilian, E. Z., Wallace, D. L., Wells, R. S., Flower, D. R., Morgan, G., & Beverley, P. C. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.1308 · Cited by 179
CD45 ectodomain controls interaction with GEMs and Lck activity for optimal TCR signaling
Irles, C., Symons, A., Michel, F., Bakker, T. R., van der Merwe, P. A., & Acuto, O. (2003) · Nature Immunology · doi:10.1038/ni877 · Cited by 178
Mechanisms of Immunosuppression in Cytomegalovirus Mononucleosis. II. Virus-Monocyte Interactions
Carney, W. P., & Hirsch, M. (1981) · The Journal of Infectious Diseases · doi:10.1093/infdis/144.1.47 · Cited by 168
Furukawa, T., Itoh, M., Krueger, N. X., Streuli, M., & Saito, H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10928 · Cited by 164
Michelson, S., Alcamí, J., Kim, S. J., Danielpour, D., Bachelerie, F., Picard, L., Chable-Bessia, C., Paya, C. V., & Virelizier, J. L. (1994) · Journal of Virology · doi:10.1128/jvi.68.9.5730-5737.1994 · Cited by 161
Ilangumaran, S., Arni, S., van Echten‐Deckert, G., Borisch, B., & Hoessli, D. C. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.4.891 · Cited by 155
Sénéchal, B., Boruchov, A. M., Reagan, J. L., Hart, D. N. J., & Young, J. W. (2004) · Blood · doi:10.1182/blood-2003-12-4350 · Cited by 152
Design of 5′ Untranslated Sequences in Retroviral Vectors Developed for Medical Use
Hildinger, M., Abel, K. L., Ostertag, W., & Baum, C. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.4083-4089.1999 · Cited by 150
Schambach, A., Mueller, D., Galla, M., Verstegen, M. M. A., Wagemaker, G., Loew, R., Baum, C., & Bohne, J. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302807 · Cited by 148
Reciprocal regulation of lymphocyte activation by tyrosine kinases and phosphatases
Hermiston, M. L., Xu, Z., Majeti, R., & Weiss, A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14794 · Cited by 146
Reciprocal regulation of lymphocyte activation by tyrosine kinases and phosphatases
Hermiston, M. L., Xu, Z., Majeti, R., & Weiss, A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214794 · Cited by 132
Terry, L. A., Brown, M. H., & Beverley, P. C. L. (1988) · PubMed · Cited by 130
Razonable, R. R. (2005) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/62.suppl_1.s7 · Cited by 119
Re-Engineering Adenovirus Vector Systems to Enable High-Throughput Analyses of Gene Function
Stanton, R. J., McSharry, B. P., Armstrong, M., Tomašec, P., & Wilkinson, G. W. G. (2008) · BioTechniques · doi:10.2144/000112993 · Cited by 116
Self-citationMembrane Domains in Lymphocytes – From Lipid Rafts to Protein Scaffolds
Harder, T., & Engelhardt, K. R. (2004) · Traffic · doi:10.1111/j.1600-0854.2003.00163.x · Cited by 115
Human Cytomegalovirus Open Reading Frame TRL11/IRL11 Encodes an Immunoglobulin G Fc-Binding Protein
Lilley, B. N., Ploegh, H. L., & Tirabassi, R. S. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.11218-11221.2001 · Cited by 107
Homology between the human cytomegalovirus RL11 gene family and human adenovirus E3 genes
Davison, A. J., Akter, P., Cunningham, C., Dolan, A., Addison, C., Dargan, D. J., Hassan‐Walker, A. F., Emery, V. C., Griffiths, P. D., & Wilkinson, G. W. G. (2003) · Journal of General Virology · doi:10.1099/vir.0.18856-0 · Cited by 101
Stone, J. D., Conroy, L. A., Byth, K. F., Hederer, R. A., Howlett, S., Takemoto, Y., Holmes, N. J., & Alexander, D. R. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.12.5773 · Cited by 99
Mee, P. J., Turner, M., Basson, M. A., Costello, P. S., Zamoyska, R., & Tybulewicz, V. L. J. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199909)29:09<2923::aid-immu2923>3.0.co;2-y · Cited by 95
D’Oro, U., Sakaguchi, K., Appella, E., & Ashwell, J. D. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4996 · Cited by 94
Young, J. L., Ramage, J. M., Gaston, H., & Beverley, P. C. L. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270937 · Cited by 92
A Survival Game of Hide and Seek: Cytomegaloviruses and MHC Class I Antigen Presentation Pathways
Basta, S., & Bennink, J. R. (2003) · Viral Immunology · doi:10.1089/088282403322396064 · Cited by 91
CD45 Glycosylation controls T‐cell life and death
Earl, L. A., & Baum, L. G. (2008) · Immunology and Cell Biology · doi:10.1038/icb.2008.46 · Cited by 89
A point mutation in the human CD45 gene associated with defective splicing of exon A
Thude, H., Hundrieser, J., Wonigeit, K., & Schwinzer, R. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250745 · Cited by 73
Self-citationTransendothelial chemotaxis of human αβ and γδ T lymphocytes to chemokines
Roth, S. J., Diacovo, T. G., Brenner, M. B., Rosat, J., Buccola, J. M., Morita, C. T., & Springer, T. A. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199801)28:01<90::aid-immu90>3.0.co;2-5 · Cited by 71
Simultaneous infection of healthy people with multiple human cytomegalovirus strains
Meyer‐König, U., Ebert, K., Schrage, B., Pollak, S., & Hufert, F. T. (1998) · The Lancet · doi:10.1016/s0140-6736(05)70487-6 · Cited by 71
Cale, C. M., Klein, N. J., Novelli, V. M., Veys, P. A., Jones, A., & Morgan, G. (1997) · Archives of Disease in Childhood · doi:10.1136/adc.76.2.163 · Cited by 70
Regulation of the p70zap tyrosine protein kinase in T cells by the CD45 phosphotyrosine phosphatase
Mustelin, T., Williams, S., Tailor, P., Couture, C., Zenner, G., Burn, P., Ashwell, J. D., & Altman, A. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250413 · Cited by 67
McKenney, D. W., Onodera, H., Gorman, L. Z., Mimura, T., & Rothstein, D. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24949 · Cited by 62
Rachmilewitz, J., Borovsky, Z., Riely, G. J., Miller, R. E., & Tykocinski, M. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211716200 · Cited by 59
Development of T‐leukaemias in CD45 tyrosine phosphatase‐deficient mutant lck mice
Baker, M., Gamble, J., Tooze, R. M., Higgins, D., Yang, F. T., O'Brien, P. C. M., Coleman, N., Pingel, S., Turner, M., & Alexander, D. R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.17.4644 · Cited by 55
Virus subversion of immunity: a structural perspective
Gewurz, B. E., Gaudet, R., Tortorella, D., Wang, E. W., & Ploegh, H. L. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00239-9 · Cited by 54
Borst, E. M., Benkartek, C., & Messerle, M. (2007) · Current Protocols in Immunology · doi:10.1002/0471142735.im1032s77 · Cited by 53
Self-citationA point mutation within CD45 exon A is the cause of variant CD45RA splicing in humans
Zilch, C. F., Walker, A. M., Timón, M., Goff, L. K., Wallace, D. L., & Beverley, P. C. L. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199801)28:01<22::aid-immu22>3.0.co;2-7 · Cited by 47
Binding of human and animal immunoglobulins to the IgG Fc receptor induced by human cytomegalovirus
Antonsson, A., & Johansson, P. J. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-5-1137 · Cited by 44
MacCormac, L. P., & Grundy, J. E. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.6.1151 · Cited by 44
Ogilvy, S., Louis-Dit-Sully, C., Cooper, J. C., Cassady, R. L., Alexander, D. R., & Holmes, N. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.4.1792 · Cited by 44
A Unique CD45 Glycoform Recognized by the Serum Mannan-binding Protein in Immature Thymocytes
Uemura, K., Yokota, Y., Kozutsumi, Y., & Kawasaki, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.9.4581 · Cited by 41
Görzer, I., Kerschner, H., Redlberger‐Fritz, M., & Puchhammer‐Stöckl, E. (2010) · Journal of Clinical Virology · doi:10.1016/j.jcv.2010.03.005 · Cited by 41
CYTOMEGALOVIRUS‐INDUCED IMMUNOSUPPRESSIONa
Hirsch, M., & Felsenstein, D. (1984) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1984.tb37117.x · Cited by 38
Windheim, M., & Burgert, H.-G. (2002) · Journal of Virology · doi:10.1128/jvi.76.2.755-766.2002 · Cited by 35
Hitomi, S., Kozuka‐Hata, H., Chen, Z., Sugano, S., Yamaguchi, N., & Watanabe, S. (1997) · Archives of Virology · doi:10.1007/s007050050169 · Cited by 33
Do, H.-T., Baars, W., Borns, K., Windhagen, A., & Schwinzer, R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.931 · Cited by 32
Self-citationIsh‐Shalom, E., Gargir, A., André, S., Borovsky, Z., Ochanuna, Z., Gabius, H., Tykocinski, M. L., & Rachmilewitz, J. (2005) · Glycobiology · doi:10.1093/glycob/cwj053 · Cited by 32
Schwinzer, R., Schraven, B. L., Kyas, U., Meuer, S. C., & Wonigeit, K. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220433 · Cited by 29
Self-citationBaldwin, T. A., & Ostergaard, H. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.7.3829 · Cited by 25
Timón, M., Arnaiz‐Villena, A., Ruíz-Contreras, J., Ramos-Amador, J. T., Pacheco, A., & Regueiro, J. R. (1993) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb05974.x · Cited by 21
Windhagen, A., Sönmez, D., Hornig‐Do, H., Kalinowsky, A., & Schwinzer, R. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03508.x · Cited by 19
Self-citationParikh, K., Poppema, S., Peppelenbosch, M. P., & Visser, L. (2008) · Blood · doi:10.1182/blood-2008-04-150987 · Cited by 17
Xu, H., & Littman, D. R. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb26655.x · Cited by 14
Giebel, S., Maccario, R., Lilleri, D., Zecca, M., Avanzini, M. A., Marconi, M., Merlone, A. D. C., Campanini, G., Montagna, D., Travaglino, P., et al. (2005) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705094 · Cited by 12
Cited by
Quantitative Temporal Viromics: An Approach to Investigate Host-Pathogen Interaction
Weekes, M. P., Tomasec, P., Huttlin, E. L., Fielding, C. A., Nusinow, D., Stanton, R. J., Wang, E. C. Y., Aicheler, R., Murrell, I., Wilkinson, G. W. G., et al. (2014) · Cell · doi:10.1016/j.cell.2014.04.028 · Cited by 431
Self-citationCD45 in human physiology and clinical medicine
Rheinländer, A., Schraven, B., & Bommhardt, U. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.01.009 · Cited by 294
Protein tyrosine phosphatase receptor type C (PTPRC or CD45)
Al Barashdi, M. A., Ali, A., McMullin, M. F., & Mills, K. (2021) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2020-206927 · Cited by 242
Martinez-Martin, N., Ramani, S. R., Hackney, J. A., Tom, I., Wranik, B. J., Chan, M., Wu, J., Paluch, M. T., Takeda, K., Hass, P. E., et al. (2017) · Nature Communications · doi:10.1038/ncomms16150 · Cited by 242
Sijmons, S., Thys, K., Mbong Ngwese, M., Van Damme, E., Dvorak, J., Van Loock, M., Li, G., Tachezy, R., Busson, L., Aerssens, J., et al. (2015) · Journal of Virology · doi:10.1128/jvi.00578-15 · Cited by 180
Metadata
- Authors
- Gabaev, I., Steinbrück, L., Pokoyski, C., Pich, A., Stanton, R. J., Schwinzer, R., Schulz, T. F., Jacobs, R., Messerle, M., & Kay-Fedorov, P. C.
- Affiliations
- Medizinische Hochschule Hannover (DE)
- Cardiff University (GB)
- Corresponding author
- Messerle, Martin
- ORCID
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-12-08
- Volume
- 7
- Issue
- 12
- Pages
- e1002432
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC3234252
- OpenAlex
- W2001518190
- Cited by
- 58
- References
- 97
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 3 · 2023: 6 · 2022: 3 · 2021: 3 · 2020: 2 · 2019: 3 · 2018: 6 · 2017: 1 · 2016: 5 · 2015: 5 · 2014: 11 · 2013: 4
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Deutsche Forschungsgemeinschaft
- Medizinischen Hochschule Hannover
- Topics
- Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- human cytomegalovirus, CD45, receptor tyrosine phosphatase, T cell suppression, T cell receptor signaling, Lck kinase, T cell proliferation, viral immunomodulation, tyrosine phosphorylation
- MeSH terms
- Cell Line, Cell Separation, Cytomegalovirus Infections, Cytomegalovirus, Flow Cytometry, Humans, Mass Spectrometry, T-Lymphocytes, Transfection, Viral Proteins, Leukocyte Common Antigens, Microscopy, Confocal, Reverse Transcriptase Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.